No spike in opioid analgesics after OTC codeine ban

Researchers refute the pharmacy guild's warning that patients would start seeking higher-strength analgesics

There has been no spike in GP scripts for opioid analgesics since over-the-counter codeine was banned from pharmacy shelves last year, a new analysis of PBS data suggests.

The Pharmacy Guild of Australia had claimed that patients would use GP visits to request higher-strength, PBS-funded analgesics after OTC codeine was banned in February 2018.